Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibiting Autophagy in Renal Cell Cancer and the Associated Tumor Endothelium.
Russell KL, Gorgulho CM, Allen A, Vakaki M, Wang Y, Facciabene A, Lee D, Roy P, Buchser WJ, Appleman LJ, Maranchie J, Storkus WJ, Lotze MT. Russell KL, et al. Among authors: facciabene a. Cancer J. 2019 May/Jun;25(3):165-177. doi: 10.1097/PPO.0000000000000374. Cancer J. 2019. PMID: 31135523 Free PMC article. Review.
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance.
Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, Giglio A, George SS, Uribe-Herranz M, Costabile F, Pierini S, Pustylnikov S, Skoufos G, Barash Y, Hatzigeorgiou AG, Koumenis C, Maity A, Lotze MT, Facciabene A. Perales-Linares R, et al. Among authors: facciabene a. Cancer Res. 2023 Nov 1;83(21):3562-3576. doi: 10.1158/0008-5472.CAN-22-2499. Cancer Res. 2023. PMID: 37578274 Free PMC article.
The dark side of tumor-associated endothelial cells.
De Sanctis F, Ugel S, Facciponte J, Facciabene A. De Sanctis F, et al. Among authors: facciabene a. Semin Immunol. 2018 Feb;35:35-47. doi: 10.1016/j.smim.2018.02.002. Epub 2018 Feb 26. Semin Immunol. 2018. PMID: 29490888 Review.
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Yegya-Raman N, Wright CM, LaRiviere MJ, Baron JA, Lee DY, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Maity A, Facciabene A, Paydar I, Plastaras JP. Yegya-Raman N, et al. Among authors: facciabene a. Clin Transl Radiat Oncol. 2023 Jan 20;39:100587. doi: 10.1016/j.ctro.2023.100587. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36718252 Free PMC article.
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
Ugel S, Facciponte JG, De Sanctis F, Facciabene A. Ugel S, et al. Among authors: facciabene a. Cancer Immunol Immunother. 2015 Oct;64(10):1339-48. doi: 10.1007/s00262-015-1747-8. Epub 2015 Aug 13. Cancer Immunol Immunother. 2015. PMID: 26267042 Free PMC article. Review.
44 results